Question 1

What is Bridge Pharma (United States) known for?

Accepted Answer

In research, Bridge Pharma (United States) stands highest in Medicine (#10,903 of 14,558 worldwide) and Health Sciences (#12,648 of 16,688 worldwide), over all time.

Question 2

How does Bridge Pharma (United States) rank in research?

Accepted Answer

Bridge Pharma (United States) ranks #18,056 of 22,385 institutions worldwide on research quality in 2022-now (#21,143 all time), and #2,651 of 3,332 in the United States.

Question 3

Who are the top researchers at Bridge Pharma (United States)?

Accepted Answer

Ranked on the quality score, Fredric J. Cohen, Luana Pesco Koplowitz and Liana Hennum lead among researchers whose main affiliation is Bridge Pharma (United States).

Question 4

What are the most cited papers from Bridge Pharma (United States)?

Accepted Answer

The most cited paper from Bridge Pharma (United States) is "Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine" (Ling Qin, Irina Kufareva, Lauren G. Holden et al., 2015), with 394 citations. Next come "Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review" (357) and "Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia" (301).

Question 5

Which research topics does Bridge Pharma (United States) publish most on?

Accepted Answer

By volume in 2022-now: Amyloidosis: Diagnosis, Treatment, Outcomes, Structural Engineering and Vibration Analysis, Myeloproliferative Neoplasms: Diagnosis and Treatment and Parathyroid Disorders and Treatments.

Question 6

Which keywords describe research at Bridge Pharma (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Treatment, Diagnosis, Prognosis, Drug Discovery, Chronic Kidney Disease, Cardiac Amyloidosis, Transthyretin and Neuroinflammation.

Question 7

Which fields of science does Bridge Pharma (United States) work in?

Accepted Answer

In 2022-now, 36% of research at Bridge Pharma (United States) is in Health Sciences, 29% in Physical Sciences. Its largest fields are Medicine (33%), Engineering (14%), Biochemistry, Genetics and Molecular Biology (13%). It does 1.6× the world's share of Life Sciences.

Question 8

Is Bridge Pharma (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 60% higher than in 2018-2021.